Question 1

What are the potential benefits of using 18F-PSMA PET/MRI compared to standard imaging methods?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer clinical trial (NCT05815316). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the results of this imaging affect my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer clinical trial (NCT05815316). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the risks or side effects associated with the PET/MRI procedure?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer clinical trial (NCT05815316). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to visit for this trial, and how long will the process take?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer clinical trial (NCT05815316). Contact the study team or your healthcare provider for specific answers.

Question 5

Are there any costs involved, or is this covered by insurance?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer clinical trial (NCT05815316). Contact the study team or your healthcare provider for specific answers.

Question 6

What happens if I do not qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the 18F-PSMA PET/MRI for the Diagnosis of Clinically Significant Prostate Cancer clinical trial (NCT05815316). Contact the study team or your healthcare provider for specific answers.

What this study is about